AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18450845 — intervention group
Group type: COMPARATOR
Intervention: Antenatal steroids 1 to 7 days before delivery (ideal group)
Number of subjects: 56
Study 18450845 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal steroids 8 to 14 days before delivery (remote group subgroup)
Number of subjects: 56
Study 18450845 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal steroids > 14 days before delivery (remote group subgroup)
Number of subjects: 56
Study 16141012 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted lidocaine application (Er:YAG laser, fluence 3.5 J/cm², pulse width 600 microseconds, spot diameter 6 mm)
Number of subjects: 30
Study 16141012 — intervention group
Group type: COMPARATOR
Intervention: Sham laser application
Number of subjects: 30
Study 16141012 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of pain levels
Number of subjects: 30
Study 12685512 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 15
Study 12685512 — intervention group
Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 15
Study 12685512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 10069551 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritanserin 2.5 mg/day
Number of subjects: 493
Study 10069551 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritanserin 5 mg/day
Number of subjects: 493
Study 10069551 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritanserin 10 mg/day
Number of subjects: 493
Study 10069551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 493
Study 7745335 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subgallate and adrenaline paste applied to the tonsillar fossae during tonsillectomy
Number of subjects: 98
Study 2033414 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly pulses of vincristine-prednisone (VCR-PDN) during maintenance therapy
Number of subjects: 631
Study 2033414 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy with mercaptopurine (6MP) and methotrexate (MTX) alone
Number of subjects: 631
Study 7343274 — intervention group
Group type: EXPERIMENTAL
Intervention: Endralazine (initial dose 2.5 mg three times daily, increased to a maximum of 50 mg daily)
Number of subjects: 27
Study 7343274 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine
Number of subjects: 27
Study 7343274 — intervention group
Group type: EXPERIMENTAL
Intervention: Endralazine
Number of subjects: 27
Study 28776930 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused treatment for youth at high risk (FFT-HR), 12 sessions in 4 months of family psychoeducation and skills training.
Number of subjects: 133
Study 28776930 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care (EC), 6 individual and family sessions over 4 months.
Number of subjects: 133
Study 28776930 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused treatment for youth at high risk (FFT-HR)
Number of subjects: 133
Study 28351509 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake >95% probability of adequate intake (PA) maintained over 2 years
Number of subjects: 179
Study 28351509 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake >95% probability of adequate intake (PA) maintained over 3 years
Number of subjects: 179
Study 28351509 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake at 6 years
Number of subjects: 179
Study 28351509 — intervention group
Group type: COMPARATOR
Intervention: Calcium intake <95% probability of adequate intake (PA)
Number of subjects: 179
Study 27926458 — intervention group
Group type: EXPERIMENTAL
Intervention: 3g/d of long‐chain omega‐3 fatty acids (1856mg EPA and 1232mg DHA)
Number of subjects: 66
Study 27926458 — intervention group
Group type: COMPARATOR
Intervention: High‐oleic safflower oil (control)
Number of subjects: 66
Study 26492776 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin
Number of subjects: 0
Study 26492776 — intervention group
Group type: COMPARATOR
Intervention: Less lipid-lowering therapy
Number of subjects: 0
Study 22992964 — intervention group
Group type: EXPERIMENTAL
Intervention: Low flow anaesthesia (0.8 L min(‐1) air-oxygen-sevoflurane (1-3 MAC))
Number of subjects: 75
Study 22992964 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow anaesthesia (6 L min‐1)
Number of subjects: 75
Study 22992964 — intervention group
Group type: COMPARATOR
Intervention: Low flow anaesthesia (0.8 L min(‐1)) in non-cancer patients
Number of subjects: 75
Study 19168444 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg
Number of subjects: 8
Study 19168444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 17466785 — intervention group
Group type: EXPERIMENTAL
Intervention: ACUSEAL patch
Number of subjects: 200
Study 17466785 — intervention group
Group type: COMPARATOR
Intervention: Finesse patch
Number of subjects: 200
Study 16401653 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (0.5mg)
Number of subjects: 16
Study 16401653 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (200mg)
Number of subjects: 16
Study 16401653 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of pramipexole and modafinil
Number of subjects: 16
Study 16401653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 12514291 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactation counseling
Number of subjects: 188
Study 12514291 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lactation counseling)
Number of subjects: 188
Study 11044538 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination pill
Number of subjects: 54
Study 11044538 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-pill
Number of subjects: 54
Study 11044538 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study 8793454 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation
Number of subjects: 15
Study 1355952 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg)
Number of subjects: 12
Study 1355952 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyzine (25 mg)
Number of subjects: 12
Study 1355952 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6337005 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopamidol
Number of subjects: 40
Study 6337005 — intervention group
Group type: COMPARATOR
Intervention: Metrizamide
Number of subjects: 40
Study 31801164 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help app for Syrian refugees with posttraumatic stress
Number of subjects: 140
Study 31801164 — intervention group
Group type: EXPERIMENTAL
Intervention: Snowball sampling recruitment strategy
Number of subjects: 140
Study 31801164 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strategic recruitment approach
Number of subjects: 140
Study 30375109 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose: paracetamol 15 mg/kg + ibuprofen 4.5 mg/kg
Number of subjects: 251
Study 30375109 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dose: paracetamol 12 mg/kg + ibuprofen 3.6 mg/kg
Number of subjects: 251
Study 30375109 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of the fixed-dose combination
Number of subjects: 251
Study 26571159 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral slump test (ST)
Number of subjects: 61
Study 26571159 — intervention group
Group type: COMPARATOR
Intervention: Control (ST)
Number of subjects: 61
Study 26571159 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 61
Study 24752957 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (10 mg/kg, maximum 500 mg)
Number of subjects: 120
Study 24752957 — intervention group
Group type: COMPARATOR
Intervention: Rifampicin (10 mg/kg, maximum 450 mg)
Number of subjects: 120
Study 24752957 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 120
Study 24752957 — intervention group
Group type: COMPARATOR
Intervention: Rifampicin
Number of subjects: 120
Study 24752957 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin and Rifampicin
Number of subjects: 120
Study 22905454 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 20
Study 22905454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 20663795 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH analogues
Number of subjects: 47
Study 20663795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 17610348 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 41
Study 17610348 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 41
Study 17610348 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Metformin and Simvastatin
Number of subjects: 41
Study 16282000 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (pharmacological or psychological)
Number of subjects: 439
Study 16282000 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher symptom score (measured by GHQ)
Number of subjects: 439
Study 16282000 — intervention group
Group type: EXPERIMENTAL
Intervention: Being male
Number of subjects: 439
Study 16282000 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety disorder
Number of subjects: 439
Study 16282000 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic mixed anxiety/depression
Number of subjects: 439
Study 12849425 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory drugs (including glucocorticoid therapy, hydroxychloroquine, NSAIDs)
Number of subjects: 0
Study 12849425 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 0
Study 12849425 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoid therapy
Number of subjects: 0
Study 12849425 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 0
Study 10200132 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (200 micrograms daily, b.i.d. for 3 weeks)
Number of subjects: 17
Study 7779545 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (G1)
Number of subjects: 84
Study 7779545 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery disease without MI history (G2)
Number of subjects: 84
Study 7779545 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (G3 and G4)
Number of subjects: 84
Study 2099245 — intervention group
Group type: EXPERIMENTAL
Intervention: Home monitoring of blood pressure
Number of subjects: 15
Study 2099245 — intervention group
Group type: COMPARATOR
Intervention: Hospital monitoring of blood pressure
Number of subjects: 15
Study 2099245 — intervention group
Group type: EXPERIMENTAL
Intervention: Circadian rhythm analysis of systolic BP
Number of subjects: 15
Study 2099245 — intervention group
Group type: EXPERIMENTAL
Intervention: Circadian rhythm analysis of diastolic BP
Number of subjects: 15
Study 6117726 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin small-particle aerosol treatment
Number of subjects: 31
Study 6117726 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 31
Study 31747001 — intervention group
Group type: EXPERIMENTAL
Intervention: Workers who perceived work-relatedness (WR+)
Number of subjects: 209
Study 31747001 — intervention group
Group type: COMPARATOR
Intervention: Workers who did not perceive work-relatedness (WR-)
Number of subjects: 209
Study 30744452 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment arm (target DBP <70 mm Hg)
Number of subjects: 8944
Study 30744452 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment group (target DBP ≥70 mm Hg)
Number of subjects: 8944
Study 27932608 — intervention group
Group type: EXPERIMENTAL
Intervention: Pocapavir (n = 93)
Number of subjects: 144
Study 27932608 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 48)
Number of subjects: 144
Study 25331699 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% LTX-109
Number of subjects: 100
Study 25331699 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% LTX-109
Number of subjects: 100
Study 25331699 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 100
Study 23899131 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold compress
Number of subjects: 17
Study 23899131 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide (3% solution)
Number of subjects: 17
Study 23899131 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-counter bruise serum
Number of subjects: 17
Study 23899131 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed dye laser (PDL)
Number of subjects: 17
Study 23899131 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 17
Study 21504885 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 76
Study 21504885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 20002471 — intervention group
Group type: EXPERIMENTAL
Intervention: Alanine aminotransferase (ALT)
Number of subjects: 41111
Study 20002471 — intervention group
Group type: COMPARATOR
Intervention: Geographic regions (Asia vs others)
Number of subjects: 41111
Study 17223803 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflation with air via a facepiece attached to a self‐inflating bag
Number of subjects: 160
Study 17223803 — intervention group
Group type: COMPARATOR
Intervention: Standard procedure without inflation
Number of subjects: 160
Study 15370406 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% retinaldehyde with non-ablative laser (1540 nm Er:glass, 10 J/cm2 per pulse, three pulses, 2 Hz repetition rate, 4 mm spot, +5 degrees C cooling)
Number of subjects: 16
Study 15370406 — intervention group
Group type: COMPARATOR
Intervention: Excipient with non-ablative laser (1540 nm Er:glass, 10 J/cm2 per pulse, three pulses, 2 Hz repetition rate, 4 mm spot, +5 degrees C cooling)
Number of subjects: 16
Study 11474633 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemifloxacin (320 mg once daily)
Number of subjects: 571
Study 11474633 — intervention group
Group type: COMPARATOR
Intervention: Trovafloxacin (200 mg once daily)
Number of subjects: 571
Study 11474633 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemifloxacin
Number of subjects: 571
Study 11474633 — intervention group
Group type: COMPARATOR
Intervention: Trovafloxacin
Number of subjects: 571
Study 9740930 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micrograms clonidine
Number of subjects: 60
Study 9740930 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms clonidine
Number of subjects: 60
Study 9740930 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 micrograms clonidine
Number of subjects: 60
Study 9740930 — intervention group
Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 60
Study 9740930 — intervention group
Group type: EXPERIMENTAL
Intervention: 75, 100 and 150 micrograms clonidine
Number of subjects: 60
Study 8311309 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural/enflurane anesthesia
Number of subjects: 26
Study 8311309 — intervention group
Group type: COMPARATOR
Intervention: Enflurane alone
Number of subjects: 26
Study 3171225 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone iv in single daily doses of 75 mg/kg for children and 3-4 g for adults for seven days
Number of subjects: 63
Study 3171225 — intervention group
Group type: COMPARATOR
Intervention: Chloramphenicol 60 mg/kg a day orally or iv in four divided doses until defervescence and then 40 mg/kg a day to complete 14 days
Number of subjects: 63
Study 31726935 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing images of infants
Number of subjects: 101
Study 31726935 — intervention group
Group type: COMPARATOR
Intervention: Viewing images of adults
Number of subjects: 101
Study 30347104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricoid pressure (Sellick group)
Number of subjects: 3472
Study 30347104 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure group
Number of subjects: 3472
Study 28419027 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive-belief treatment (inert capsule described as a potent supplement)
Number of subjects: 627
Study 28419027 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-belief treatment (inert capsule described as a potent supplement)
Number of subjects: 627
Study 28419027 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (received neither instruction nor capsule)
Number of subjects: 627
Study 28419027 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to use supplements (within positive-belief treatment)
Number of subjects: 627
Study 26514221 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (2 g)
Number of subjects: 60
Study 26514221 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular tranexamic acid (2 g)
Number of subjects: 60
Study 26514221 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tranexamic acid)
Number of subjects: 60
Study 23306586 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensity (HI) continuous renal replacement therapy (CRRT)
Number of subjects: 115
Study 23306586 — intervention group
Group type: COMPARATOR
Intervention: Lower intensity (LI) continuous renal replacement therapy (CRRT)
Number of subjects: 115
Study 21680125 — intervention group
Group type: EXPERIMENTAL
Intervention: CT fluoroscopy (CTF)
Number of subjects: 60
Study 21680125 — intervention group
Group type: COMPARATOR
Intervention: Electromagnetic navigation system (EMN)
Number of subjects: 60
Study 18084791 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram treatment
Number of subjects: 0
Study 16406123 — intervention group
Group type: EXPERIMENTAL
Intervention: Encouraged to drink 240 ml of clear liquid prior to discharge
Number of subjects: 93
Study 16406123 — intervention group
Group type: COMPARATOR
Intervention: Voluntary drinking of liquids
Number of subjects: 93
Study 16406123 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (encouraged and voluntary)
Number of subjects: 93
Study 12875940 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy
Number of subjects: 91
Study 12875940 — intervention group
Group type: COMPARATOR
Intervention: Deferred hormonal treatment
Number of subjects: 91
Study 12875940 — intervention group
Group type: COMPARATOR
Intervention: Immediate hormonal treatment
Number of subjects: 91
Study 12875940 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 91
Study 12875940 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate vs Deferred hormonal treatment
Number of subjects: 91
Study 12751395 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic sodium chloride solution (0.5 to 2.0 mL depending on age) during suctioning
Number of subjects: 24
Study 12751395 — intervention group
Group type: COMPARATOR
Intervention: No isotonic sodium chloride solution during suctioning
Number of subjects: 24
Study 10195518 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine (0.1 mL/kg) with 1:200,000 epinephrine (0.5 microg/kg)
Number of subjects: 32
Study 10195518 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 32
Study 7624902 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hydrochlorothiazide
Number of subjects: 10
Study 7624902 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral furosemide
Number of subjects: 10
Study 7624902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous furosemide
Number of subjects: 10
Study 7624902 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 10
Study 2507548 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous supplementation of enteral calories, n = 16
Number of subjects: 39
Study 2507548 — intervention group
Group type: COMPARATOR
Intervention: Enteral calories alone, n = 23
Number of subjects: 39
Study 892120 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone acetonide suspension
Number of subjects: 12
Study 892120 — intervention group
Group type: EXPERIMENTAL
Intervention: Kromayer lamp (contact irradiation with ultraviolet light)
Number of subjects: 12
Study 30623683 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 39
Study 30623683 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional exercise
Number of subjects: 39
Study 30623683 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 30663175 — intervention group
Group type: EXPERIMENTAL
Intervention: Acotiamide (100 mg tid)
Number of subjects: 20
Study 30663175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 27993649 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentive feedback
Number of subjects: 2
Study 27993649 — intervention group
Group type: COMPARATOR
Intervention: Non-monetary feedback
Number of subjects: 2
Study 26394822 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD stimulant medication
Number of subjects: 8420
Study 26394822 — intervention group
Group type: COMPARATOR
Intervention: No ADHD stimulant medication
Number of subjects: 8420
Study 23712475 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (anterior cervical decompression and fixation) followed by anti-tuberculous medications (16 patients)
Number of subjects: 29
Study 23712475 — intervention group
Group type: COMPARATOR
Intervention: Conservative management (anti-tuberculous medications only) (13 patients)
Number of subjects: 29
Study 22000478 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (10mg/kg/day)
Number of subjects: 33
Study 22000478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 19544166 — intervention group
Group type: EXPERIMENTAL
Intervention: montelukast + loratadine
Number of subjects: 406
Study 19544166 — intervention group
Group type: COMPARATOR
Intervention: beclomethasone
Number of subjects: 406
Study 19544166 — intervention group
Group type: COMPARATOR
Intervention: montelukast
Number of subjects: 406
Study 18001247 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Number of subjects: 82
Study 18001247 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03%
Number of subjects: 82
Study 15551197 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (PAROX) and Amitriptyline (AMI) in OPEN condition
Number of subjects: 127